4//SEC Filing
CytomX Therapeutics, Inc. 4
Accession 0001140361-16-091061
$CTMXCIK 0001501989operating
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 3:52 PM ET
Size
6.9 KB
Accession
0001140361-16-091061
Insider Transaction Report
Form 4
HUMPHREY RACHEL
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2016-12-28$6.61/sh+15,117$99,994→ 15,117 total - Exercise/Conversion
Stock Option (Right to Buy)
2016-12-28−15,117→ 278,097 totalExercise: $6.61Exp: 2025-08-27→ Common Stock (15,117 underlying)
Footnotes (1)
- [F1]This option vests 25% on August 28, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day of the month, except the final installment, which shall vest on August 28, 2019.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001501989
Filing Metadata
- Form type
- 4
- Filed
- Dec 28, 7:00 PM ET
- Accepted
- Dec 29, 3:52 PM ET
- Size
- 6.9 KB